Literature DB >> 27550843

Dysregulation of the glutamatergic receptors after antidepressant treatment in human neural progenitor cells.

C Cruceanu1, J P Lopez1, W-T Tsai1, G Turecki1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27550843     DOI： 10.1038/mp.2016.138

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN： 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  8 in total

Review 1.  The history of the pharmacology and cloning of ionotropic glutamate receptors and the development of idiosyncratic nomenclature.

Authors:  David Lodge
Journal:  Neuropharmacology       Date:  2008-08-14       Impact factor: 5.250

2.  Hallucinogen-induced UP states in the brain slice of rat prefrontal cortex: role of glutamate spillover and NR2B-NMDA receptors.

Authors:  Evelyn K Lambe; George K Aghajanian
Journal:  Neuropsychopharmacology       Date:  2005-11-02       Impact factor: 7.853

Review 3.  Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.

Authors:  Gerard Sanacora; Giulia Treccani; Maurizio Popoli
Journal:  Neuropharmacology       Date:  2011-08-03       Impact factor: 5.250

Review 4.  The chemical nature of the main central excitatory transmitter: a critical appraisal based upon release studies and synaptic vesicle localization.

Authors:  F Orrego; S Villanueva
Journal:  Neuroscience       Date:  1993-10       Impact factor: 3.590

Review 5.  Metabotropic glutamate receptors as novel targets for anxiety and stress disorders.

Authors:  Chad J Swanson; Mark Bures; Michael P Johnson; Anni-Maija Linden; James A Monn; Darryle D Schoepp
Journal:  Nat Rev Drug Discov       Date:  2005-02       Impact factor: 84.694

6.  Sex differences in glutamate receptor gene expression in major depression and suicide.

Authors:  A L Gray; T M Hyde; A Deep-Soboslay; J E Kleinman; M S Sodhi
Journal:  Mol Psychiatry       Date:  2015-07-14       Impact factor: 15.992

Review 7.  Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders.

Authors:  Gerard Sanacora; Carlos A Zarate; John H Krystal; Husseini K Manji
Journal:  Nat Rev Drug Discov       Date:  2008-05       Impact factor: 84.694

8.  miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment.

Authors:  Juan Pablo Lopez; Raymond Lim; Cristiana Cruceanu; Liam Crapper; Caroline Fasano; Benoit Labonte; Gilles Maussion; Jennie P Yang; Volodymyr Yerko; Erika Vigneault; Salah El Mestikawy; Naguib Mechawar; Paul Pavlidis; Gustavo Turecki
Journal:  Nat Med       Date:  2014-06-08       Impact factor: 53.440
  8 in total
  2 in total

1.  Co-Variation of Peripheral Levels of miR-1202 and Brain Activity and Connectivity During Antidepressant Treatment.

Authors:  Juan Pablo Lopez; Fabricio Pereira; Stéphane Richard-Devantoy; Marcelo Berlim; Eduardo Chachamovich; Laura M Fiori; Paola Niola; Gustavo Turecki; Fabrice Jollant
Journal:  Neuropsychopharmacology       Date:  2017-01-12       Impact factor: 7.853

2.  Investigation of miR-1202, miR-135a, and miR-16 in Major Depressive Disorder and Antidepressant Response.

Authors:  Laura M Fiori; Juan Pablo Lopez; Stéphane Richard-Devantoy; Marcelo Berlim; Eduardo Chachamovich; Fabrice Jollant; Jane Foster; Susan Rotzinger; Sidney H Kennedy; Gustavo Turecki
Journal:  Int J Neuropsychopharmacol       Date:  2017-08-01       Impact factor: 5.176
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.